Clinical Trial Update: Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy [Phase 1, Phase 2]

View source ↗

Summary

This update covers a Phase 1/2 trial of MRI-guided differential-dose brachytherapy for prostate cancer, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED